SYSTEMIC IMMUNOMODULATING THERAPIES FOR STEVENS-JOHNSON SYNDROME AND TOXIC EPIDERMAL NECROLYSIS IN A COVID-19 PATIENT. A CASE REPORT
European Journal of Clinical Pharmacy
; 23(4):258-262, 2021.
Article
in English
| EMBASE | ID: covidwho-1955706
ABSTRACT
Stevens-Johnson syndrome and toxic epidermal necrolysis are rare serious disorders that affect the skin and mucous membranes. These reactions are most commonly caused by drugs and, rarely, infections. While discontinuing the offending drug and supportive care are primordial, there are no consensus treatment guidelines on the optimal use of systemic immunomodulatory agents. Here, we report a case of a 57-year-old woman, who had recently recovered from COVID-19 infection, with Stevens-Johnson syndrome/toxic epidermal necrolysis overlap most likely triggered by dorzolamide eye drops. The patient was successfully treated with a single subcutaneous dose of etanercept combined with oral cyclosporine, corticosteroids and intravenous immunoglobulins. The progression of skin lesions ceased after administration of etanercept. In addition, a significant clinical improvement was observed a few days after treatment with immunoglobulins, without complications or important side effects.
acute phase protein; bisoprolol; ceftriaxone; clindamycin; cyclosporine; D dimer; dorzolamide; etanercept; ferritin; glucose; immunoglobulin; immunoglobulin G antibody; immunoglobulin M antibody; losartan; mupirocin; permanganate potassium; prednisone; sulfadiazine silver; timolol; adult; antibiotic therapy; article; body surface; case report; clinical article; conjunctivitis; controlled study; coronavirus disease 2019; dental erosion; disease control; disease exacerbation; emergency ward; epithelization; erythema multiforme; eyelid erythema; female; fever; genital system disease; glaucoma; glucose blood level; good general condition; histopathology; home care; hospital admission; hospitalization; human; human tissue; hypertension; immunotherapy; lymphocyte count; lymphocytopenia; medical history; micturition disorder; middle aged; mortality; mucosa inflammation; pain measurement; physical examination; rash; single drug dose; skin biopsy; skin defect; Stevens Johnson/toxic epidermal necrolysis overlap syndrome; systemic therapy; topical treatment; treatment outcome; visual analog scale
Search on Google
Collection:
Databases of international organizations
Database:
EMBASE
Type of study:
Case report
Language:
English
Journal:
European Journal of Clinical Pharmacy
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS